Dapsone Tablet
Product Images NDC 70954-136

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dapsone (NDC 70954-136). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Daspone-100mg-30's Count (Dapsone 100 mg 30s Count)

Label for Dapsone Tablets USP 100 mg oral tablets, featuring a 30-tablet count. Manufactured by Novitium Pharma LLC, New Jersey. The label includes storage instructions, dosage note, and a barcode. The product is prescription only and highlights the active ingredient strength, 100 mg Dapsone per tablet.*

FDA Label Image

Dapsone-25mg-30s-count (Dapsone 25 mg 30s Count)

Label for DAPSONE 25 mg oral tablets by ANI Pharmaceuticals, Inc. The label states each tablet contains 25 mg of Dapsone and includes storage instructions to keep the drug at controlled room temperature. The package contains 30 tablets and is marked Rx only. The label also shows the NDC number and manufacturer details for Novitium Pharma LLC.*

FDA Label Image

Structure (Dapsone Structure)

Chemical structure of dapsone showing two benzene rings connected by a sulfone group, with each benzene ring substituted with an amino group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.